Kisspeptin Mitigates Hepatic De Novo Lipogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Open Access
Abstract
The peptide hormone kisspeptin, signaling via its receptor, KISS1R, decreases hepatic steatosis and protects against metabolic dysfunction-associated steatotic liver disease (MASLD). Enhanced de novo lipogenesis (DNL) contributes to MASLD. Here, we investigated whether kisspeptin treatment in obese, diabetic mice directly attenuates DNL. DNL was assessed in kisspeptin-treated mouse livers, using a mouse model of MASLD, (DIAMOND mice), employing 2H2O-enriched water, mass spectrometry analysis, and transcriptomic profiling. Gene and protein expression were evaluated in primary hepatocytes and livers. Additionally, hepatic Kiss1r expression was increased in DIAMOND mice, following which various biochemical and metabolic assessments were employed. Metabolic tracing in kisspeptin-treated steatotic livers demonstrated a decrease in the DNL of free fatty acids (FFAs), known to be associated with diabetes, steatosis, and hepatocellular carcinoma. Transcriptomic profiling of kisspeptin-treated livers identified disruption of key metabolic pathways, the most prominent being a decrease in fatty acid metabolism, and downregulation of Cidea, a key regulator of lipid droplet formation. Kisspeptin treatment of FFA-loaded primary mouse hepatocytes significantly decreased Cidea expression. Mechanistically, we found that kisspeptin administration decreased levels of transcription factor SREBP-1c, a crucial regulator of DNL, and CIDEA. Thus, enhanced KISS1R signaling limits hepatic DNL, suggesting a crucial role in restricting MASLD.Keywords
Funding Information
- Rutgers NJ Institute for Food Nutrition and Health S.D.G. (R01DK129870)
This publication has 61 references indexed in Scilit:
- IDI1 inhibits the cGAS-Sting signaling pathway in hepatocellular carcinomaHeliyon, 2024
- Regulation and targeting of SREBP-1 in hepatocellular carcinomaCancer and Metastasis Reviews, 2023
- Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular CarcinomaBiochemical Genetics, 2021
- Control of lipid droplet fusion and growth by CIDE family proteinsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017
- Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver diseaseFEBS Open Bio, 2017
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancerJournal of Hepatology, 2016
- Glucagon Regulates Hepatic Kisspeptin to Impair Insulin SecretionCell Metabolism, 2014
- Cidea promotes hepatic steatosis by sensing dietary fatty acidsHepatology, 2012
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant MiceCell Metabolism, 2011
- Regulation of hepatocyte fate by interferon-γCytokine & Growth Factor Reviews, 2011